Lv5
1180 积分 2024-02-27 加入
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
26天前
已完结
Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial
7个月前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
9个月前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
9个月前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
9个月前
已完结
Tirzepatide for Obesity Treatment and Diabetes Prevention
10个月前
已完结
皖公网安备34019202002308
